STROBE: A beaconfor observational studies

Archives of Dermatology

Volumn 144, Issue 9, 2008, Pages 1200-1204

  Nijsten, Tamar ^a   Spuls, Phyllis ^b   Stern, Robert S ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; ISOTRETINOIN;

CANCER MORTALITY; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; HUMAN; MEDICAL LITERATURE; MELANOMA; MORTALITY; NOTE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS; SUICIDE; TOXIC EPIDERMAL NECROLYSIS;

EID: 51949099401     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.9.1200     Document Type: Note

References (14)

1. The CONSORT Statement. http://www.consort-statement.org/?o=1011. Updated October 22, 2007. Accessed December 13, 2007.
2. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. http: //www.agreecollaboration.org/pdf/agreeinstrumentfinal.pdf. Published September 2001. Accessed December 13, 2007.
3. Ebrahim S, Clarke M. STROBE: new standards for reporting observational epidemiology: a chance to Improve. Int J Epidemiol. 2007:36(5):946-948.
4. Editors. Probing STROBE. Epidemiology. 2007:18(6):789-790.
5. MacMahon B, Weiss NS. Is there a dark phase of this STROBE? Epidemiology. 2007;18(6):791.
6. The STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). http://www.strobe-statement.org/. Updated May 14,2008. Accessed December 13, 2007.
7. Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol. 2007;56(2):181-200.
8. Strahan JE, Raimer S. Isotretinoin and the controversy of psychiatric adverse effects. Int J Dermatol.;45(7):789-799.
9. Bigby ME. The end of the sunscreen and melanoma controversy? Arch Dermatol. 2004;140(6):745-746.
10. Moher D, Jones A, Lepage L; CONSORT Group (Consolidated Standards for Reporting of Trials). Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA. 2001 ;285 (15):1992-1995.
11. von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007:147(8):573-577.
12. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies In Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297.
13. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies In Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007;18(6):805-835.
14. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. 2nd ed. Edinburgh, Scotland: Churchill Livingstone; 2000.